Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$256,048
New position
Shares Held
1,474
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#285
of 422 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Marex Group plc holds $5,474,048 across 11 Diagnostics & Research names. ICLR ranks #10 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,266 | $1,136,081 | |
| 2 | DHR |
Danaher Corp /De/
|
4,403 | $838,682 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
2,551 | $578,540 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,007 | $530,124 | |
| 5 | NTRA |
Natera, Inc.
|
1,705 | $462,822 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,600 | $448,000 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,801 | $381,721 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,752 | $365,548 |
All Filings in ICLR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,048 | 1,474 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||